Societe Generale Effekten (S27015) Quote

shane s on larry pesavento 130pm

The flipper$$ will run out of ammo very quickly with massive per market pre$$ure coming $weet$$$

"But we would now like to do some more focused, faster path, tumor shrinkage endpoint trials. So we are, as we evaluate, I mean, we have so many opportunities in front of us now. Really, the challenge is choosing. Right? And so we we gotta steer ourselves, to the extent we can, towards that directio

If you think someone posting on this board is pumping/moving shares in any company, you’re delusional. The audience is so small, it can’t possibly have an impact one way or another. The only thing it can do is help someone that is following a company with their research.

I don’t und

"Super" Happy *BirthDay*, Capgain " .. !!

Trump on Gutfield last night was great.

its easy to see a communicator would make a much better President.

no notes, no teleprompter, no agenda, just down earth talking.

chill out, u might wake your boyfriend.

Rolled up the 30’$$$ $weet$$ $moking it like a joint$$$$$

FDA fa$t track on $tandby new$$$ $weet$$$

Ok

Thank you for your monthly BIEL post. I see you’re still banging the table!

#1 Life is 10% what happens to you and 90% how you react to it.
Charles R. Swindoll
#2 If you have the facts, bang on the facts, if you have opinion bang on opinion, if you

Pre-market pressure $weet$$$$ Grab all you can at the$e level$$ a gift from heaven above$$$$$

$GNS no 🧠’er buy & hold for FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, determining

$GNS no 🧠’er buy & hold for FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, determining

Who will take u$ to heaven $weet$$$
Bristol Myers Squibb

AstraZeneca

Merck

Novartis

Roche

AbbVie

Johnson & Johnson

Accord Healthcare

Amgen

Astellas Pharma

Filing to shut down American OTC this qtr. product no longer at any locations.

The 500 share trades are odd but hardly nefarious and imo the stock is trading brilliantly with traders selling and buying .

Now the topic isnt labeled corruption now it's nefarious . Lol

If there was anything nefarious going on the stock would not be trading like it i

JPM: “ Despite raising our price target to reflect more value for future product royalties, we struggle to find a strong upside case from current levels that does not rely on giving even more credit. With the stock now at $62/sh, we are moving to the sidelines and lowering our rating to reflect HALO

1776Rebel, you seem to be coming around to the truth. It's painful, but it is better to know than to remain under an illusion.

Linda said they were still doing development work on Eden for optimization as of the ASM. That definitely means that they cannot already have completed all their needed testing and moved into an MHRA evaluation at this point in time. Though that was as of the ASM so the current status on finalizing

Global Ice Maker Market Size

Summary:

The global ice maker market size reached US$ 5.1 Billion in 2023.
The market is expected to reach US$ 7.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.
North America leads the market, accou

As I feared, JPM downgraded to neutral even though they raised their Dec. ‘25 PT from $52 to $57. They are moving to the sidelines because they feel it is more than fully valued. Basically, they want to see the “broad-based” discussions turn into new partnerships. The bigger the partner, the more it

thats good news, hope it sticks